Many schoolgirls have suffered ill-effects from receiving the Cervarix injection / cervical cancer vaccine
The UK Government introduced a systematic program of vaccination in April 2008 to protects girls from the sexually transmitted human papillomavirus which causes 70 per cent of cervical tumours.
When the Government introduced the Cervarix vaccination programme last year, some campaigners dubbed it a “promiscuity jab”. The vaccine was developped by Galxosmithkline.
In total the drug safety watchdog Medicines and Health care products Regulatory Agency (MHRA) has recorded so far about more than 2,000 suspected reactions but these were overall mild, with dozens of girls recording rashes, pain in the arm, and allergies.
A support group says it has received dozens of calls from parents who believe their daughters have been damaged by the vaccine.
The parents of one teenage girl given the jab last autumn believe it was to blame for repeated seizures which have left her with brain damage and psychosis.
The report prepared by the MHRA earlier this month also discloses cases in which teens have suffered convulsions, eye rolling, muscle spasms, seizures and hyperventilation soon after being given the jab.
The analysis by the MHRA, drawn up this month, found 2,107 patients had reported some kind of suspected adverse reaction to Cervarix. Several reported multiple reactions, with 4,602 suspected side-effects recorded in total.
Jackie Fletcher, founder of Jabs, a support group for families whose children have fallen ill after immunisation, said she had taken dozens of calls from parents who believed their daughters had been damaged by the cervical cancer vaccine.
She said: “We have spoken to parents whose daughters have had seizures, paralysis, blurred vision, severe headaches and the loss of feeling in parts of their body.
“Doctors will try to convince parents that these problems are in their child’s mind, or have nothing to do with the vaccines, but we don’t think there is sufficient evidence to show Cervarix is safe.”
Medical safety experts insist the benefits of the vaccine outweigh the risks.
A spokesman for GlaxoSmithKline, which makes Cervarix, said the drug had to undergo rigorous testing, with over 70,000 doses used in trials before a licence was granted.